Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era

Nutrition Reviews

Volumn 73, Issue 8, 2015, Pages 523-543

  Abdullah, Mohammad M H ^a   Jones, Peter J H ^a,b   Eck, Peter K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

cardiovascular disease; circulating cholesterol; gene diet interaction; personalized nutrition; single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER G1; ABC TRANSPORTER G5; ABC TRANSPORTER SUBFAMILY A; APOLIPOPROTEIN A1; CHOLESTEROL 7ALPHA MONOOXYGENASE; FATTY ACID BINDING PROTEIN 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 3; CHOLESTEROL;

ANTHROPOMETRY; ARTICLE; BODY WEIGHT GAIN; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LEVEL; CHOLESTEROL METABOLISM; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DNA POLYMORPHISM; FASTING; FAT INTAKE; FOLLOW UP; GENE EXPRESSION; GENETIC POLYMORPHISM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; LIPID DIET; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; METABOLIC PATHWAY ANALYSIS; NUTRIGENETICS; NUTRITIONAL ASSESSMENT; OBESITY; OBSERVATIONAL STUDY; PERSONALIZED NUTRITION; PHYSICAL ACTIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; FEEDING BEHAVIOR; GENETICS; LIPID METABOLISM; METABOLISM; NUTRIGENOMICS; NUTRITIONAL STATUS;

CHOLESTEROL; DIET; FOOD HABITS; HUMANS; LIPID METABOLISM; NUTRIGENOMICS; NUTRITIONAL STATUS; POLYMORPHISM, GENETIC;

EID: 84956675801     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/NUTRIT/NUV016     Document Type: Article

References (114)

1. Green ED, Guyer MS, National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470: 204-213.
2. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10:109-121.
3. Asselbergs FW, Guo Y, van Iperen EP, et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet. 2012;91: 823-838.
4. Elbers CC, Guo Y, Tragante V, et al. Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One. 2012;7:e50198. doi:10.1371/journal.pone.0050198.
5. Surendran RP, Visser ME, Heemelaar S, et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med. 2012;272:185-196.
6. Hindorff LA, MacArthur J, Morales J, et al. A catalog of published genome-wide association studies. www.genome.gov/gwastudies. Accessed March 22, 2014.
7. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
8. Phillips CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013;5:32-57.
9. Smith CE, Arnett DK, Tsai MY, et al. Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis. 2009;206:500-504.
10. Liu WY, Yin RX, Zhang L, et al. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels. Alcohol. 2011;45:681-687.
11. Junyent M, Tucker KL, Smith CE, et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res. 2009;50:565-573.
12. Aslibekyan S, Goodarzi MO, Frazier-Wood AC, et al. Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One. 2012;7:e48663. doi:10.1371/journal.pone.0048663.
13. Walker CG, Holzapfel C, Loos RJ, et al. Genetic predisposition to an adverse lipid profile limits the improvement in total cholesterol in response to weight loss. Obesity. 2013;21:2589-2595.
14. Hall K, Murrell J, Ogunniyi A, et al. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology. 2006; 66:223-227.
15. Akadam-Teker B, Kurnaz O, Coskunpinar E, et al. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease. Gene. 2013;528:93-98.
16. Romero-Hidalgo S, Villarreal-Molina T, Gonzalez-Barrios JA, et al. Carbohydrate intake modulates the effect of the ABCA1-R230C variant on HDL cholesterol concentrations in premenopausal women. J Nutr. 2012;142:278-283.
17. Abellan R, Mansego ML, Martinez-Hervas S, et al. Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis. 2011;219:900-906.
18. Viturro E, de Oya M, Lasuncion MA, et al. Cholesterol and saturated fat intake determine the effect of polymorphisms at ABCG5/ABCG8 genes on lipid levels in children. Genet Med. 2006;8:594-599.
19. Hwang JY, Park JE, Choi YJ, et al. Carbohydrate intake interacts with SNP276G>T polymorphism in the adiponectin gene to affect fasting blood glucose, HbA1C, and HDL cholesterol in Korean patients with type 2 diabetes. J Am Coll Nutr. 2013;32:143-150.
20. Phillips CM, Goumidi L, Bertrais S, et al. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk. Atherosclerosis. 2011;214:408-414.
21. Rudkowska I, Dewailly E, Hegele RA, et al. Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr. 2013;109:953-961.
22. Hubacek JA, Bohuslavova R, Skodova Z, et al. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med. 2007;45:316-320.
23. Brown S, Ordovas JM, Campos H. Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins. Atherosclerosis. 2003;170:307-313.
24. Yang Y, Ruiz-Narvaez E, Kraft P, et al. Effect of apolipoprotein E genotype and saturated fat intake on plasma lipids and myocardial infarction in the Central Valley of Costa Rica. Hum Biol. 2007;79:637-647.
25. Hubacek JA, Pitha J, Skodova Z, et al. Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem. 2003;36: 263-267.
26. Chamberlain AM, Schreiner PJ, Fornage M, et al. Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism. 2009;58:1222-1228.
27. Freitas RN, Khaw KT, Wu K, et al. A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene (HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study. Br J Nutr. 2010;104:765-772.
28. Nettleton JA, Steffen LM, Ballantyne CM, et al. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis. 2007;194:e131-e140.
29. Riestra P, Lopez-Simon L, Ortega H, et al. Fat intake influences the effect of the hepatic lipase C-514T polymorphism on HDL-cholesterol levels in children. Exp Biol Med. 2009;234:744-749.
30. Tai ES, Corella D, Deurenberg-Yap M, et al. Dietary fat interacts with the - 514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr. 2003;133:3399-3408.
31. Kim Y, Lee M, Lim Y, et al. The gene-diet interaction, LPL PvuII and HindIII and carbohydrate, on the criteria of metabolic syndrome: KMSRI-Seoul Study. Nutrition. 2013;29:1115-1121.
32. Baik I, Lee S, Kim SH, et al. A lipoprotein lipase gene polymorphism interacts with consumption of alcohol and unsaturated fat to modulate serum HDL-cholesterol concentrations. J Nutr. 2013;143:1618-1625.
33. Robitaille J, Houde A, Lemieux S, et al. The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-a and dietary cholesterol intake in French-Canadians. Br J Nutr. 2007; 97:11-18.
34. Fontaine-Bisson B, Wolever TM, Connelly PW, et al. NF-jB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis. 2009;204: 465-470.
35. Volcik KA, Nettleton JA, Ballantyne CM, et al. Peroxisome proliferator-activated receptor a genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2008;87:1926-1931.
36. Robitaille J, Gaudet D, Perusse L, et al. Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canadians. Int J Obes. 2007;31:411-417.
37. Memisoglu A, Hu FB, Hankinson SE, et al. Interaction between a peroxisome proliferator-activated receptor c gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923-2929.
38. Fontaine-Bisson B, Wolever TM, Chiasson JL, et al. Genetic polymorphisms of tumor necrosis factor-a modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr. 2007;86:768-774.
39. Joffe YT, van der Merwe L, Carstens M, et al. Tumor necrosis factor-a gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black South African women. J Nutr. 2010;140:901-907.
40. Joffe YT, van der Merwe L, Collins M, et al. The -308 G/A polymorphism of the tumour necrosis factor-a gene modifies the association between saturated fat intake and serum total cholesterol levels in white South African women. Genes Nutr. 2011;6:353-359.
41. Joffe YT, van der Merwe L, Evans J, et al. The tumor necrosis factor-a gene -238G>A polymorphism, dietary fat intake, obesity risk and serum lipid concentrations in black and white South African women. Eur J Clin Nutr. 2012;66: 1295-1302.
42. Guevara-Cruz M, Tovar AR, Larrieta E, et al. Increase in HDL-C concentration by a dietary portfolio with soy protein and soluble fiber is associated with the presence of the ABCA1R230C variant in hyperlipidemic Mexican subjects. Mol Genet Metab. 2010;101:268-272.
43. Zhao HL, Houweling AH, Vanstone CA, et al. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Lipids. 2008;43:1155-1164.
44. Gomez P, Perez-Martinez P, Marin C, et al. APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. J Nutr. 2010;140:773-778.
45. Zhang X, Qi Q, Bray GA, et al. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. Am J Clin Nutr. 2012;96:917-922.
46. Jemaa R, Mebazaa A, Fumeron F. Apolipoprotein B signal peptide polymorphism and plasma LDL-cholesterol response to low-calorie diet. Int J Obes Relat Metab Disord. 2004;28:902-905.
47. Song YY, Gong RR, Zhang Z, et al. A high-carbohydrate diet enhances the adverse effect of the S2 allele of APOC3 SstI polymorphism on the TG/HDL-C ratio only in young Chinese females. Braz J Med Biol Res. 2011;44:524-530.
48. Sanchez-Muniz FJ, Maki KC, Schaefer EJ, et al. Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype. J Nutr. 2009;139:13-19.
49. Moreno JA, Perez-Jimenez F, Moreno-Luna R, et al. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Br J Nutr. 2009;101:1745-1752.
50. Tucker AJ, Mackay KA, Robinson LE, et al. The effect of whole grain wheat sourdough bread consumption on serum lipids in healthy normoglycemic/normoinsulinemic and hyperglycemic/hyperinsulinemic adults depends on presence of the APOE E3/E3 genotype: a randomized controlled trial. Nutr Metab. 2010;7:37. doi:10.1186/1743-7075-7-37.
51. Moreno JA, Perez-Jimenez F, Marin C, et al. Apolipoprotein E gene promoter -219G!T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat. Am J Clin Nutr. 2004; 80:1404-1409.
52. Madden J, Carrero JJ, Brunner A, et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids. 2008;78:327-335.
53. Goyenechea E, Collins LJ, Parra D, et al. CD36 gene promoter polymorphisms are associated with low density lipoprotein-cholesterol in normal twins and after a low-calorie diet in obese subjects. Twin Res Hum Genet. 2008;11:621-628.
54. Du J, Fang DZ, Lin J, et al. TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults. J Nutr Biochem. 2010;21:1114-1119.
55. De Castro-Oros I, Pampin S, Cofan M, et al. Promoter variant -204A > C of the cholesterol 7a-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr. 2011;30:239-246.
56. Kovar J, Suchanek P, Hubacek JA, et al. The A-204C polymorphism in the cholesterol 7a-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res. 2004;53:565-568.
57. Hofman MK, Weggemans RM, Zock PL, et al. CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr. 2004;134:2200-2204.
58. de Luis DA, Aller R, Izaola O, et al. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diabetes Res Clin Pract. 2008;82: 113-118.
59. Pishva H, Mahboob SA, Mehdipour P, et al. Fatty acid-binding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects. Nutrition. 2010;26:1117-1121.
60. Rubin D, Helwig U, Pfeuffer M, et al. The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols. Genes Nutr. 2012;7: 437-445.
61. Huang X, Gong R, Lin J, et al. Effects of lipoprotein lipase gene variations, a high-carbohydrate low-fat diet, and gender on serum lipid profiles in healthy Chinese Han youth. Biosci Trends. 2011;5:198-204.
62. Alsaleh A, O'Dell SD, Frost GS, et al. Interaction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk. J Lipid Res. 2011; 52:2298-2303.
63. Hamada T, Kotani K, Nagai N, et al. Low-calorie diet-induced reduction in serum HDL cholesterol is ameliorated in obese women with the -3826 G allele in the uncoupling protein-1 gene. Tohoku J Exp Med. 2009;219:337-342.
64. Luis DA, Aller R, Izaola O, et al. Modulation of insulin concentrations and metabolic parameters in obese patients by -55CT polymorphism of the UCP3 gene secondary to two hypocaloric diets. Horm Metab Res. 2009;41:62-66.
65. Oram JF, Vaughan AM. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99:1031-1043.
66. Frikke-Schmidt R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis. 2010;208: 305-316.
67. Kusuhara H, Sugiyama Y. ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch. 2007;453:735-744.
68. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290: 1771-1775.
69. Torres N, Guevara-Cruz M, Granados J, et al. Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. Nutr Res. 2009;29:728-735.
70. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006;16:141-146.
71. Perez-Martinez P, Lopez-Miranda J, Cruz-Teno C, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr. 2008;138:1609-1614.
72. Warodomwichit D, Shen J, Arnett DK, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity. 2009;17:510-517.
73. Lund-Katz S, Phillips MC. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 2010;51:183-227.
74. Holleboom AG, Vergeer M, Hovingh GK, et al. The value of HDL genetics. Curr Opin Lipidol. 2008;19:385-394.
75. Schaefer EJ. Lipoproteins, nutrition, and heart disease. Am J Clin Nutr. 2002;75: 191-212.
76. Herron KL, Lofgren IE, Adiconis X, et al. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis. 2006;184:113-120.
77. Oliveira Sousa M, Alia P, Pinto X. Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease [in Spanish]. Med Clin. 2008; 130:787-793.
78. Hubacek JA. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med. 2005;43:897-902.
79. Lai CQ, Corella D, Demissie S, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113:2062-2070.
80. Contois JH, McConnell JP, Sethi AA, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2009;55:407-419.
81. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population. Nutr Metab Cardiovasc Dis. 2007;17: 224-229.
82. Ordovas JM. The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 1999;58:171-187.
83. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141:137-147.
84. Aitken WA, Chisholm AW, Duncan AW, et al. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat. Nutr Metab Cardiovasc Dis. 2006; 16:353-363.
85. Petkeviciene J, Smalinskiene A, Luksiene DI, et al. Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population. PLoS One. 2012;7:e41525. doi:10.1371/journal.pone.0041525.
86. Banuls C, Martinez-Triguero ML, Lopez-Ruiz A, et al. Serum lipid responses to phytosterol-enriched milk in a moderate hypercholesterolemic population is not affected by apolipoprotein E polymorphism or diameter of low-density lipoprotein particles. Eur J Clin Nutr. 2011;65:255-261.
87. Corella D, Portoles O, Arriola L, et al. Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort. J Nutr Biochem. 2011;22:487-494.
88. Carvalho-Wells AL, Jackson KG, Lockyer S, et al. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am J Clin Nutr. 2012;96:1447-1453.
89. Pfeuffer M, Auinger A, Bley U, et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis. 2013;23:403-409.
90. Wu K, Bowman R, Welch AA, et al. Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J. 2007;28:2930-2936.
91. Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr. 2002;22:383-415.
92. Cucuianu M, Coca M, Hancu N. Reverse cholesterol transport and atherosclerosis. A mini review. Rom J Intern Med. 2007;45:17-27.
93. Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955-1966.
94. Barcelos AL, Chies R, Almeida SE, et al. Association of CYP7A1 -278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients. Braz J Med Biol Res. 2009;42:487-493.
95. Albala C, Santos JL, Cifuentes M, et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res. 2004;12: 340-345.
96. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990; 343:425-430.
97. Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol. 2004;3:271-278.
98. Smirnov AN. Lipid signaling in the atherogenesis context. Biochemistry. 2010;75: 793-810.
99. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, et al. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol. 2004;24: 1750-1754.
100. Tsutsumi K. Lipoprotein lipase and atherosclerosis. Curr Vasc Pharmacol. 2003;1: 11-17.
101. Anderson JL, King GJ, Bair TL, et al. Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol. 1999;33:1013-1020.
102. Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995;9:1033-1045.
103. Kumar A, Takada Y, Boriek AM, et al. Nuclear factor-jB: its role in health and disease. J Mol Med. 2004;82:434-448.
104. Temel RE, Tang W, Ma Y, et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007;117: 1968-1978.
105. Hegele RA, Guy J, Ban MR, et al. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Lipids Health Dis. 2005;4:16.
106. Cohen JC, Pertsemlidis A, Fahmi S, et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A. 2006;103:1810-1815.
107. Ramachandran U, Kumar R, Mittal A. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome. Mini Rev Med Chem. 2006;6:563-573.
108. Robitaille J, Brouillette C, Houde A, et al. Association between the PPARa-L162V polymorphism and components of the metabolic syndrome. J Hum Genet. 2004; 49:482-489.
109. Paradis AM, Fontaine-Bisson B, Bosse Y, et al. The peroxisome proliferator-activated receptor a Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am J Clin Nutr. 2005;81:523-530.
110. Matsuo T, Nakata Y, Katayama Y, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity. 2009;17:1924-1931.
111. Tai ES, Corella D, Deurenberg-Yap M, et al. Differential effects of the C1431T and Pro12Ala PPARc gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004;45:674-685.
112. Jovinge S, Hamsten A, Tornvall P, et al. Evidence for a role of tumor necrosis factor a in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism. 1998;47:113-118.
113. Warne JP. Tumour necrosis factor a: a key regulator of adipose tissue mass. J Endocrinol. 2003;177:351-355.
114. Cioffi F, Senese R, de Lange P, et al. Uncoupling proteins: a complex journey to function discovery. Biofactors. 2009;35:417-428.